![](\"https:\/\/mms.businesswire.com\/media\/20260603061898\/en\/2823558\/5\/FNIH_Logo.jpg\"){kind=logo}
<\/a><\/a>\n\u201cEffective partnerships help fuel scientific progress. By bringing together creative, passionate individuals and organizations, we accelerate discoveries that improve human health,\u201d said FNIH President and CEO Julie Gerberding, MD, MPH. \u201cWe are deeply grateful to these remarkable awardees for their commitment to \u2018team science\u2019 and biomedical research.\u201d<\/p>
\nDoctoroff<\/a> is the founder of Target ALS, the largest global ALS research-focused nonprofit organization and a partner in the Accelerating Medicines Partnership\u00ae<\/sup> (AMP\u00ae<\/sup>) Amyotrophic Lateral Sclerosis (ALS) program. He was instrumental in designing and launching AMP ALS, working closely with FNIH to bring together a diverse group of partners. Under his leadership, AMP ALS initiated the ALS Knowledge Portal, which will become the largest data source for ALS research and support ongoing data sharing, collaboration and discovery.<\/p> \nBiogen<\/a> is a longstanding and committed partner, supporting FNIH public-private partnerships for 15 years. The company has advanced numerous initiatives across immunology and neuroscience, providing financial and strategic support for projects within the FNIH Biomarkers Consortium, AMP and the Alzheimer\u2019s Disease Neuroimaging Initiative.<\/p> \nNIAMS<\/a>, one of NIH\u2019s 27 Institutes and Centers, played a key role in developing the AMP program, a public-private partnership between NIH, life sciences companies, patient communities and philanthropic groups to transform the current model for developing new diagnostics and treatments. Today, NIAMS continues to advance bold research as the NIH lead of AMP Autoimmune and Immune-Mediated Diseases. NIAMS is also a key contributing member of the FNIH Biomarkers Consortium.<\/p> \nThe Charles A. Sanders, MD, Partnership Award is named for the founding Chairman of the FNIH Board of Directors. The recipients will be awarded at the 14th Annual FNIH Awards Ceremony<\/a> on the evening of Oct. 28, 2026, in Washington, D.C. The 2026 Montrone-Seigel Prize in Biomedical Sciences, the Paul-Gallin Trailblazer Prize for Physician-Scientists and the Kovler Prize for Trust in Life Science Journalism also will be presented.<\/p> \nThe FNIH gratefully acknowledges Annual Awards Ceremony Premier Sponsors Fred and Donna Seigel.<\/p> \nFor more information about the Partnership Award, visit FNIH.org\/sandersaward<\/a>.<\/p> \nAbout the Foundation for the National Institutes of Health\n